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Herpes simplex virus 1 (HSV-1) UL13 is a viral protein kinase that is packaged into virions and regulates optimal expression of ICP0 and
a subset of late (g) proteins, including UL41 in infected cells. In the present study, we investigated the role(s) of the protein kinase activity of
UL13 in viral replication using a recombinant virus expressing enzymatically inactive UL13 after an amino acid substitution in the invariant
lysine of UL13. The recombinant virus carrying this mutation formed smaller plaques yielded 10-fold less progeny than wild-type virus but
could not be differentiated from wild-type virus with respect to accumulation of UL41 and ICP0 in infected cells. These results indicate that
the protein kinase activity of UL13 plays a role in viral replication in cell culture, but the activity is not essential for the optimal expression of
UL41 and ICP0.
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To date, herpes simplex virus 1 (HSV-1) is known to
encode at least 84 different proteins (Roizman and Knipe,
2001). The genes of HSV-1 consist of three major groups,
designated a, h and g, whose expression is coordinately
regulated and sequentially ordered in cascade fashion (Roiz-
man and Knipe, 2001). Of the viral genes, UL13, Us3 and
UL39 genes are of particular interest because they encode
protein kinases (Roizman and Knipe, 2001). It is well
known that phosphorylation of proteins by protein kinases is0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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the activity of the target proteins. Phosphorylation of target
proteins by specific protein kinases regulates many cellular
functions, such as transcription, translation, cell cycle
regulation, protein degradation and apoptosis (Edelman et
al., 1987; Manning et al., 2002). Conceivably, HSV-1
utilizes the viral protein kinases to regulate its own repli-
cative process and to modify cellular machinery through the
phosphorylation of viral and cellular proteins. In fact, the
viral protein kinases are reported to playmultiple roles in viral
gene expression (Purves et al., 1993), apoptosis (Leopardi
et al., 1997; Perkins et al., 2002) and nuclear egress of
nucleocapsids (Reynolds et al., 2002). This report con-
cerns the protein kinase activity expressed by HSV-1 uL13
gene. The background relevant to this report is as follows.
(i) HSV-1 UL13 is a serine/threonine protein kinase and
the amino acid sequence of UL13 is conserved in all05) 301 – 312
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1997; Kawaguchi et al., 2003; Smith and Smith, 1989). Here
we refer to these conserved viral protein kinases as conserved
herpesvirus protein kinases (CHPKs). Since CHPKs are
present in all herpesviruses, they may play a conserved role in
the replication of herpesviruses by phosphorylating common
host cellular targets and conserved herpesvirus gene prod-
ucts. The only common substrate targeted by CHPKs from all
Herpesviridae subfamilies that has been identified to date is
the cellular translation factor EF-1y (Kato et al., 2001;
Kawaguchi et al., 1998, 1999). Although the biological
significance of the phosphorylation remains unclear, an
interesting feature of the interaction between CHPKs and
EF-1y is that both cellular protein kinase cdc2 and CHPKs
phosphorylate the same amino acid residue of EF-1y
(Kawaguchi and Kato, 2003; Kawaguchi et al., 2003). These
observations suggest that CHPKs potentially share a function
that mimics the cellular protein kinase cdc2. Data showing
that HSV-1 UL13 phosphorylates the cdc2 site of casein
kinase II h subunit in vitro (Kawaguchi et al., 2003) support
this hypothesis. Moreover, reports that Epstein–Barr virus
(EBV) CHPK, BGLF4 and cdc2 phosphorylate the same sites
of EBV regulatory proteins, EBNA-LP and EBNA-2, which
are critical for the transcriptional activity of the proteins both
in vitro and in vivo are consistent with the stated idea (Kato et
al., 2003; Yokoyama et al., 2001; Yue et al., 2005).
(ii) HSV-1 UL13 plays a role in viral replication in cell
cultures, since deletion mutants of UL13 exhibit impaired
capacity to replicate in some cell lines, including rabbit skin
cells and baby hamster kidney (BHK) cells (Coulter et al.,
1993; Ng et al., 1996; Purves et al., 1993; Purves and
Roizman, 1992). Although the mechanisms by which UL13
acts in HSV-1-infected cells remains unclear, infection of
rabbit skin cells and BHK cells with UL13 deletion mutants
reduces expression levels of a protein ICP0 and a subset of
g proteins, including UL26, UL26.5, UL38, UL41 and Us11
(Ng et al., 1997; Ogle and Roizman, 1999; Poon et al.,
2000; Purves et al., 1993; Roizman and Knipe, 2001), sug-
gesting that UL13 is involved in viral gene expression in
infected cells.
(iii) The UL13 protein kinase appears to mediate
phosphorylation of various viral and cellular proteins,
including gI/gE, ICP0, ICP22, Us1.5, VP22, EF-1y, p60
and RNA polymerase II because posttranslational modifi-
cation of the proteins was either precluded or reduced in
cells infected with UL13 deletion mutant viruses (Bruni
et al., 1999; Coulter et al., 1993; Durand et al., 2005;
Kawaguchi et al., 1998, 2003; Long et al., 1999; Ng et al.,
1998; Ogle et al., 1997; Purves and Roizman, 1992). It is
interesting, with respect to the accumulation of ICP0 and the
subset of g proteins, that the phenotypes of ICP22 and
Us1.5 deletion mutants, both of which are encoded by a22
gene, cannot be differentiated from that of UL13 deletion
mutant viruses (Ng et al., 1997; Ogle and Roizman, 1999;
Poon et al., 2000; Purves et al., 1993; Roizman and Knipe,
2001). Although these observations suggest that UL13exerts its regulatory function by phosphorylating ICP22
and Us1.5, the direct linkage between phosphorylation of
ICP22 and Us1.5 by UL13 and the regulatory function in
viral gene expression remains to be demonstrated.
(iv) The UL13 is packaged in the tegument, a structural
component of the virion located between the capsid and the
envelope (Cunningham et al., 1992; Overton et al., 1992),
suggesting that as a virion component the UL13 plays a role
in maintenance of virion structure and possibly, in phosphor-
ylation of other virion proteins. Tegument proteins are
generally released in the cytoplasm of newly infected cells.
Therefore, UL13 would also be expected to function in early
post-infection events by phosphorylating viral and cellular
proteins. Consistently, it has been reported that the phosphor-
ylation of tegument proteins by UL13 is implicated in
promoting tegument disassembly in vitro (Morrison et al.,
1998).
To date, most information about UL13 functions stems
from studies with deletion mutants, which probably have
defects in both the protein kinase and virion component
activities, as well as yet-to-be defined activities. The
objective of this study was to clarify the role of protein
kinase activity of UL13 in infected cells. For this purpose,
we generated a recombinant virus (YK403) by means of an
amino acid substitution in the invariant lysine of UL13,
which expresses a mutant of UL13 protein with no intrinsic
protein kinase activity, but has probably retained its overall
structure (Kawaguchi et al., 2003). In the present study, we
attempted to unveil the UL13 functions which stem solely
from its catalytic activity by comparison of the phenotypes
of YK403 with those of UL13 deletion and wild-type
viruses in cell cultures.Results
Generation of recombinant viruses encoding mutant UL13
proteins
In general, protein kinases possess several conserved
domains and, in most cases, an invariant lysine residue in
subdomain II cannot be mutated without loss of protein
kinase activity (Hanks et al., 1988). Earlier we constructed a
mutant of UL13, UL13K176M in which the lysine codon at
position 176 (lys-176), which corresponds to the invariant
lysine, was replaced by site-directed mutagenesis with
methionine (Kawaguchi et al., 2003). UL13K176M is
expressed as a protein with the same Mr as wild-type
UL13, but it has no intrinsic protein kinase activity
(Kawaguchi et al., 2003). Here we generated a recombinant
virus YK403 carrying a methionine replacement of Lys-176
in UL13 as described in Materials and methods to
investigate the role of protein kinase activity of UL13 in
infected cells. The strategy for construction of UL13 mutant
viruses is summarized in Fig. 1. We introduced mutagenesis
into the viral genome in Escherichia coli that harbored the
Fig. 1. Schematic diagram of genome structures of wild-type YK304 and relevant domains of the recombinant viruses. Line 1, a linear representation of the
YK304 genome. The unique sequences are represented as unique long (UL) and short (Us), and the terminal repeats flanking them are shown as open
rectangles with their designation given above. The YK304 genome has bacmid (BAC) in the intergenic region between UL3 and UL4. Line 2, the BglIIO
fragment and relevant restriction enzyme sites in the genome domain encoding UL12, UL13 and UL14 open reading frames. Lines 3 and 4, expected sizes of
DNA fragments generated by cleavage of DNA. The fragment designations shown here are identical to those described in the text and in Fig. 2A. Line 5,
location of the AflIII fragment used as a radiolabeled probe in Fig. 2A. Line 6, predicted amino acid sequence of UL13. The shaded areas represent subdomains
I–VI, which are conserved in eukaryotic protein kinases (Smith and Smith, 1989). Line 7, a schematic diagram of the recombinant virus, YK401. As a result of
Rec ET-mediated recombination, a kanamycin resistance cassette was inserted into a truncated UL13 gene contained an HSV-BAC maintained in an E. coli.
YK401 was reconstituted by transfection of the mutated HSV-BAC (pYEbac401) into rabbit skin cells. Line 8, a schematic diagram of the recombinant virus
YK402. As a result of Flp-mediated site-specific recombination, the kanamycin resistance cassette was excised from pYEbac401 and a single FRT site
remained. YK402 was reconstituted by transfection of the resulting HSV-BAC (pYEbac402) into rabbit skin cells. Line 9, a schematic diagram of the
recombinant virus, YK403. As a result of RecA-mediated recombination, a methionine substitution in lys-176 of UL13 was introduced into pYEbac401.
YK403 was reconstituted by transfection of the resulting HSV-BAC (pYEbac403) into rabbit skin cells. Line 10, schematic diagram of the recombinant virus,
YK404. Rescue of the YK403 by cotransfection of its DNAwith AflIII Pst+ in pBSDV-Kp yielded the recombinant YK404 in which the M176K substitution
rendered the UL13 gene wild type. Restriction sites: H, HindIII; Bg, BglII; Bs, BstEII; Af, AflIII.
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infectious genome (pYEbac102) (Tanaka et al., 2003). The
pYEbac102 contained BAC vector sequences inserted into
the intergenic region between UL3 and UL4 genes (Tanaka
et al., 2003). The recombinant viruses reconstituted from
pYEbac102 exhibited wild-type properties, such as the
ability to grow in cell cultures and virulence in mice as we
previously described (Tanaka et al., 2003).
For verification of the genome structures of the
recombinant viruses constructed here, each viral genome
that was extracted from cells infected with both the UL13
mutant and wild-type viruses was digested with BglII,
electrophoretically separated and analyzed by Southern
blotting with the 5.1-kbp AflIII fragment as a probe (Fig.
1). As could be predicted from the construction of these
viruses (Fig. 1), the probe hybridized to fragment a (5.4
kbp) in YK304, YK403 and YK404 (Fig. 2A, lanes 1, 3 and
4) and to fragment b + c (4.4 kbp) in UL13 deletion mutant
YK402 (Fig. 2A, lane 2). The presence of the desired amino
acid substitution in viral genomes of YK403 and YK404was verified by sequencing the PCR amplified fragment of
UL13 gene (Fig. 2B).
UL13K176M mutant accumulates in infected cells and is
packaged into virions to the same level as wild-type UL13
The objectives of experiments in this section were to
examine whether the amino acid substitution of lys-176
affects the accumulation of UL13 protein in infected cells and
to determine whether the substitution mutation has an effect
on the efficiency of UL13 incorporation into virions. In the
first series of experiments, rabbit skin cells were infected with
each of the recombinant viruses at MOI of 5 PFU per cell,
harvested at 18 h, solubilized, electrophoretically separated in
a denaturing gel, transferred to a polyvinylidine difluoride
(PVDF) membrane and reacted with the rabbit polyclonal
antibody to UL13 or UL34. The UL13 antiserum reacted with
wild-type UL13 (Fig. 2C, lane 1) and UL13K176M mutant
(lane 3), both of which showed the identical Mr of 57,000, but
not with the lysates from cells infected with the UL13
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UL13mutant protein in rabbit skin cells infected with YK403
was similar to that of YK304. In this experiment, UL34
served as a loading control. In the second series of experi-
ments, virions were purified from rabbit skin cells infected
with each of the recombinant viruses, solubilized and
analyzed by immunoblotting with the polyclonal antibody
to UL13 or UL48. The UL13K176M mutant was incorpo-
rated into virions at the same level as wild-type UL13 (Fig.
2D). In this experiment, UL48 served as a loading control.
These results indicate that (i) the amino acid substitution inlys-176 of UL13 had no effect on its accumulation in infected
cells and (ii) the mutation does not affect the packaging
efficiency of the protein into virions and/or stability of the
protein in virions. Taken together with our previous
observation that the methionine substitution in lys-176
abolishes the protein kinase activity of UL13 (Kawaguchi
et al., 2003), it can be concluded that the protein kinase
activity of UL13 does not influence either its expression in
infected cells or its incorporation into virions.
The posttranslational processing of ICP22 is dependent on
the protein kinase activity of UL13
The objective of the experiment in this section is to
investigate whether the protein kinase activity of UL13
mediates the posttranslational processing of ICP22. Rabbit
skin cells were either mock infected or infected with wild-
type viruses (HSV-1(F) and YK304), UL13 mutant viruses
(R7356, YK402 and YK403) or repaired virus (YK404) at
an MOI of 5 PFU per cells, harvested at 18 h after infection,
solubilized and analyzed by immunoblotting with the
polyclonal antibody to ICP22. The UL13 deletion mutant
virus R7356 was used as a control because this mutant virus
has often been used for investigation of the UL13 protein
(Kawaguchi et al., 1998, 2003; Ng et al., 1996, 1998; Ogle
et al., 1997; Poon et al., 2000; Purves and Roizman, 1992;
Purves et al., 1993). The results (Fig. 3) were as follows.
(i) The polyclonal antibody to the amino terminal peptide
of ICP22 reacted with three major bands of ICP22 (Mr of
approximately 70–80 kDa) in rabbit skin cells infected with
wild-type HSV-1(F) (lane 1) but not with mock-infected
cells (lane 7). In cells infected with the UL13 deletion
mutant R7356, the slowest-migrating band disappeared and
the amount of protein in the slow-migrating band decreased
(lane 2), indicating that the slower migrating bands in HSV-Fig. 2. (A) Autoradiographic images of electrophoretically separated BglII
digests of YK402, YK403, YK404 and YK304 DNAs, hybridized to the
radiolabeled AflIII fragment of HSV-1(F). The letters on the right refer to
the digests of the DNA fragments generated by restriction endonuclease
cleavage. Molecular sizes are shown on the left. (B) Sequence around the
invariant lysine in UL13 from YK304, YK403, YK404 and HSV-1(F).
Cytoplasmic viral DNA of each virus was obtained from infected Vero
cells, and an approximately 600-bp fragment was PCR amplified and
sequenced. The sequence of each virus was identical, with the exception of
the desired mutation shown by lines. Codon 176 encoding amino acid
residue K (nucleotides AAG) in the HSV-1(F), YK304 or YK404 genome
was replaced with codon for amino acid residue M (nucleotides ATG) in the
YK403 genome. (C) Photographic image of immunoblots of electrophoreti-
cally separated lysates of rabbit skin cells infected with YK304 (lane 1),
YK402 (lane 2) or YK403 (lane 3) at an MOI of 5 PFU per cell. The
infected rabbit skin cells were harvested at 18 h post-infection and
subjected to immunoblotting with the polyclonal antibody to UL13 (upper
panel) or UL34 (lower panel). (D) Photographic image of immunoblots of
electrophoretically separated virion polypeptides from rabbit skin cells
infected with YK304 (lane 1), YK402 (lane 2) or YK403 (lane 3). The
virions were purified from infected cells as described in Materials and
methods and subjected to immunoblotting with the polyclonal antibody to
UL13 (upper panel) or UL48 (lower panel).
Fig. 3. Photographic image of an immunoblot of electrophoretically
separated lysates of rabbit skin cells mock infected (lane 7) or infected
with HSV-1(F) (lane 1), R7356 (lane 2), YK304 (lane 3), YK402 (lane 4),
YK403 (lane 5) or YK404 (lane 6) at MOI of 5 PFU per cell. The infected
cells were harvested at 18 h post-infection and subjected to immunoblotting
with the polyclonal antibody to ICP22.
Fig. 4. (A) Photographic image of a plaque produced by YK304 (upper
panel), YK403 (middle panel) or YK404 (lower panel). Rabbit skin
cells infected with each of the recombinant viruses at MOI of 0.0001
PFU per cell under plaque assay conditions. Phase contrast photographs
were recorded 2 days after infection. (B) The mean diameters of
20 single plaques per each of the recombinant viruses were determined.
*, **P < 0.001.
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isoforms resulting from posttranslational processing of the
protein (Purves and Roizman, 1992). Previously, it has been
reported that all the isoforms of ICP22 are phosphorylated
in infected cells, based on the orthophosphate labeling
experiments (Purves and Roizman, 1992).
(ii) With regard to the posttranslational processing of
ICP22, wild-type YK304 and the UL13 deletion mutant
YK402 exhibited the same phenotypes as observed with
HSV-1(F) and R7356, respectively (lanes 1–4). The pattern
of electrophoretic mobilities of ICP22 from cells infected
with YK403 carrying amino acid substitution in lys-176 of
UL13 could not be differentiated from those of ICP22 from
cells infected with the UL13 deletion mutant viruses R7356
and YK402 (lanes 2, 4 and 5). The wild-type phenotype was
restored in cells infected with the recombinant virus YK404,
in which the K176M mutation in UL13 gene was repaired
(lane 6). Similar results were obtained with Vero cells
infected with these same recombinant viruses (data not
shown).
These results indicate that the protein kinase activity of
UL13 is critical for the posttranslational processing of
ICP22 in infected cells.
Growth properties of UL13 mutant viruses in cell cultures
To examine the role of protein kinase activity of UL13 in
viral growth in cell cultures, two series of experiments were
performed. In the first series of experiments, rabbit skin cells
were infected with wild-type virus YK304, YK403 carrying
the amino acid substitution in the lys-176 of UL13, and
repaired virus YK404 under the conditions used for plaque
assay and plaque sizes were analyzed 2 days after infection.
Plaques produced by both YK304 andYK404were of similar
size (Fig. 4). In contrast, YK403 produced smaller plaques
than both YK304 and YK404 (Fig. 4). The differences in
plaque size were statistically significant (P < 0.001).
In the second series of experiments, rabbit skin cells
were infected with YK304, YK402, YK403 or YK404, atMOIs of either 5 or 0.01 PFU per cell and harvested at the
indicated time points (Table 1). The titers of each sample
were determined by standard plaque assay on Vero cells. At
an MOI of 5, the yields of the UL13 mutant viruses,
YK402 and YK403, were slightly impaired compared to
the wild-type YK304. In contrast, at MOI of 0.01 YK402
and YK403 consistently yielded 10-fold less virus than
YK304 and repair of the K176M mutation in UL13
(YK404) restored replication kinetics to those of wild type.
Similar results were obtained in repeated experiments (data
not shown).
These results indicate that the protein kinase activity
of UL13 plays a role in viral replication in cell cultures.
Table 1
Replication of recombinant viruses in rabbit skin cellsa
MOI Hours after infection Recombinant virus titers with
YK304(%b) YK402(%b) YK403(%b) YK404(%b)
5 18 2.2  106 (100) 1.3  106 (59) 5.6  105 (25) 5.1  106 (232)
0.01 24 2.6  104 (100) 2.6  103 (10) 2.3  103 (9) 2.9  104 (112)
0.01 48 8.0  105 (100) 7.0  104 (9) 6.0  104 (7) 9.0  105 (113)
a Rabbit skin cells were infected with recombinant viruses at MOI of 5 or 0.01 per cell. The infected cell cultures were harvested and titrated on Vero cells.
b Relative to the yield of YK304.
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optimal expression of UL41 and ICP0 in infected cells
The objective of the experiments in this section was to test
whether the protein kinase activity of UL13 is involved in the
regulatory effect on the expression of UL41 in infected cells.
Rabbit skin or Vero cells were infected with wild-type virus,
YK304, UL13 deletion mutant virus, YK402, and the mutant
virus encoding the UL13K176M mutant, YK403, at an MOI
of 5, harvested at 18 h after infection, solubilized and
analyzed by immunoblotting with the monoclonal antibody
to ICP0 or polyclonal antibodies to either UL41 or UL34.
Rabbit skin and Vero cells infected with the UL13 deletion
mutant virus, YK402, expressed less UL41 proteins than cells
infected with wild-type YK304 (Fig. 5A, lanes 1, 2, 4 and 5).
These results were consistent with earlier publications (Ng et
al., 1997). In contrast, the expression levels of UL41 proteins
in cells infected with YK403 were equivalent to those in cells
infected with wild-type YK304 (lanes 1, 3, 4 and 6). In these
experiments, UL34 served as a loading control. Similarly,
ICP0 proteins were expressed at wild-type level in rabbit skin
cells infected with YK403, while YK402 produced less ICP0
proteins than cells infected with YK304 or YK403 (Fig. 5B).
These results indicate that the protein kinase activity of
UL13 is not required for optimal expression of UL41 and
ICP0 in infected cells.Fig. 5. (A) Photographic image of an immunoblot of electrophoretically
separated lysates from Vero (lanes 1–3) or rabbit skin cells (lanes 4–6)
infected with YK304 (lanes 1 and 4), YK402 (lanes 2 and 5) or YK403 (lanes
3 and 6) at MOI of 5. The infected cells were harvested at 18 h post-infection
and subjected to immunoblotting with the antibody to UL41 (upper panel)
or UL34 (lower panel). (B) Photographic image of an immunoblot of
electrophoretically separated lysates from rabbit skin cells infected with
YK304 (lane 1), YK402 (lane 2) or YK403 (lane 3) at MOI of 5. The infected
cells were harvested at 18 h post-infection and subjected to immunoblotting
with the antibody to ICP0 (upper panel) or UL34 (lower panel).Discussion
To create the cellular environment in which the viruses
can both replicate efficiently and survive in the hosts, viruses
have to regulate numerous aspects of cellular machinery.
However, viral genomes encode only limited number of
proteins, making it likely that multiple functions may be
conferred on individual viral proteins. For example, HSV
UL39 gene encodes at least two domains each of which
performs functions that are totally unrelated. The gene
encodes the large subunit of the ribonucleotide reductase
(RR1), which plays a key role in the synthesis of viral DNA,
together with the small subunit of RR encoded by UL40
(Roizman and Knipe, 2001). In contrast to the cellular RR1,
HSV UL39 gene products possess an N-terminal extension
of about 350 amino acids, which is associated with protein
kinase activity (Nikas et al., 1986; Swain and Galloway,
1986). Similarly, a regulatory protein ICP0 also consists ofseveral blocks of amino acids, each of which performs
various functions by interacting with cellular and viral
proteins (Everett et al., 1997; Hagglund and Roizman, 2004;
Kawaguchi et al., 1997a, 1997b, 2001). The protein encoded
by UL13 gene, the subject of this study, has been reported to
play roles in viral gene expression and viral replication in
cell cultures, based on the observations with UL13 deletion
mutant viruses (Coulter et al., 1993; Ng et al., 1996; Purves
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questions were whether these phenotypes of UL13 deletion
mutant viruses reported earlier stem from the protein kinase
activity or the other function(s) of the protein. In the present
study, we addressed the question. The salient features of this
study are as follows.
(i) The amino acid substitution in the invariant lysine of
UL13 had no effect on either its expression in infected cells
or its incorporation into virions, but it did preclude
posttranslational processing of ICP22 in infected cells. To
differentiate functional activity of protein kinase from that
of the other function(s) of UL13 protein, we attempted to
construct the recombinant virus YK403 that expresses a
mutant UL13 (UL13K176M) with no intrinsic protein
kinase activity, but retention of its overall structure. As
expected, the UL13K176M mutant was expressed as a
protein with the same Mr of the wild-type UL13 and the
posttranslational processing of ICP22 was precluded in cells
infected with YK403. Furthermore, the K176M mutation of
UL13 had no effect on either UL13 accumulation in infected
cells or the incorporation of the protein into virion. Two
conclusions can be drawn from these observations. First,
YK403 fulfills the requirements for our stated purpose.
Second, the protein kinase activity of UL13 is critical for the
posttranslational processing of ICP22, but not for its
expression in infected cells and its packaging into virions.
(ii) In rabbit skin cells infected with YK403 carrying the
amino acid substitution in Lys-176 of UL13, UL41 and
ICP0 proteins accumulated at the same levels as seen in
cells infected with wild-type virus, while the cells infected
with UL13 deletion mutant virus (YK402) exhibited
impaired expression of the proteins as reported previously
(Ng et al., 1997). These results indicate that the protein
kinase activity of UL13 is not essential for the optimal
expression of UL41 and ICP0 in infected cells. These
observations suggest that the UL13 gene encodes a protein
with regulatory activity for expression of the viral proteins
that is totally unrelated to its protein kinase activity. The
UL41 gene encodes a tegument protein that causes non-
specific degradation of mRNA and shutoff of macro-
molecular synthesis after infection (Roizman and Knipe,
2001).
Interestingly, the regulatory activity of UL13 appears to
be conserved among CHPKs. Thus, Ng et al. reported that
the expression defect of ICP0 and the subset of g proteins
exemplified by Us11 observed with the UL13 deletion
mutant viruses can be restored by human cytomegalovirus
UL97-encoded CHPK in infected cells (Ng et al., 1996).
This raises the possibility that the other CHPKs may also
exhibit regulatory activity for viral gene expression in
infected cells.
(iii) The amino acid substitution in the invariant lysine of
UL13 impaired both plaque forming ability and viral growth
in cell culture. Although these observations indicate that the
protein kinase activity of UL13 is beneficial to viral
replication in cell culture, the mechanism by which theprotein kinase activity acts in viral replication is unclear.
Conceivably, functional modifications of cellular and viral
targets that are mediated by the protein kinase activity of
UL13 change the activity of the UL13 target proteins.
Consistent with this idea are the findings that the protein
kinase activity of UL13 has the ability to control intra-
cellular localization of a viral protein VP22 (Geiss et al.,
2004). Furthermore, Hamza et al. reported that the protein
kinase activity of Kaposi’s sarcoma-associated herpesvirus
(KSHV) ORF36-encoded CHPK induces the activation of
the mitogen-activated stress kinase pathways, such as c-Jun
N-terminal kinase (JNK) signaling pathway (Hamza et al.,
2004). It is also noteworthy that the activation of these
signaling pathways observed in HSV-1 infected cells is also
involved in enhancement of viral replication (McLean and
Bachenheimer, 1999; Zachos et al., 1999). At present, it is
unknown whether the protein kinase activity of UL13 also
modulates these cellular signaling pathways. Based on the
observations that respective CHPK sometimes targets the
same cellular factors, such as EF-1y and RNA polymerase II
(Baek et al., 2004; Kato et al., 2001; Kawaguchi et al., 1998,
1999; Long et al., 1999), there is a possibility that the
protein kinase activity of UL13 regulates viral replication in
a manner similar to KSHV ORF36.
(iv) Amino acid substitution in the invariant lysine of
UL13 precluded the posttranslational processing of ICP22
but had no effect on the accumulation of UL41. Purves et al.
reported that UL13 mediates the posttranslational modifi-
cation of ICP22 (Purves and Roizman, 1992) and that the
phenotypes of UL13 deletion mutant viruses, with respect to
the accumulation of ICP0 and the subset of g proteins,
closely paralleled those of mutant viruses lacking ICP22
(Ng et al., 1997; Ogle and Roizman, 1999; Poon et al.,
2000; Purves et al., 1993; Roizman and Knipe, 2001). These
data stimulated efforts to resolve the question of whether
UL13 expresses its regulatory function through phosphor-
ylation of ICP22 or whether both effects are independent.
Poon et al. constructed a recombinant virus R7851 in which
a series of serine and threonine residues in the amino
terminal domain of ICP22 were substituted with alanines
(Poon et al., 2000). In cells infected with R7851, post-
translational processing of ICP22 is completely abolished,
while the subset of g proteins exemplified by UL38 and
Us11 proteins accumulated at the same level as seen in cells
infected with the wild-type virus (Poon et al., 2000). These
observations indicate that the posttranslational processing of
ICP22 is not essential for optimal expression of these viral
proteins. The same conclusion can be drawn from our
observations with the recombinant virus that did not have
UL13 protein kinase activity but did express authentic
ICP22. Our observations reinforce the previous evidence
by Poon et al. (2000) showing that ICP22 and UL13
independently regulate the expression of ICP0 and the
subset of g proteins in infected cells.
In conclusion, the protein kinase activity of UL13 plays a
role in viral replication in cell culture, but is not required for
M. Tanaka et al. / Virology 341 (2005) 301–312308optimal expression of UL41 and ICPO. These observations
led us to unveil the undefined regulatory activity of UL13,
unrelated to protein kinase activity, for viral gene expres-
sion. Further studies are needed to clarify the mechanism by
which the protein kinase activity acts on viral replication
and how UL13 regulates viral gene expression. Such studies
include identification of cellular and viral substrates of
UL13 protein kinase, elucidation of the biological signifi-
cance of the phosphorylation of the UL13 targets and
identification of cellular and viral proteins that interact with
UL13 independently of its protein kinase activity.Materials and methods
Cells and viruses
Vero and rabbit skin cells, as well as wild-type strain
HSV-1(F) and a UL13 deletion mutant virus R7356, were
described previously (Ejercito et al., 1968; Kawaguchi et al.,
2003; Purves and Roizman, 1992; Tanaka et al., 2003).
YK304 is reconstituted from pYEbac102 containing a full
length of infectious clone of HSV-1(F) in which the BAC
sequence was inserted into the intergenic region between
UL3 and UL4 (Tanaka et al., 2003). YK304 shows a
phenotype identical to those of wild-type HSV-1(F) in vitro
and in vivo (Tanaka et al., 2003).
Plasmids
To construct the Flp recombinase expression plasmid
pCP20Zeo, zeocine-resistant gene cassette was PCR ampli-
fied from pcDNA4/HisMaxC (Invitrogen) and inserted into
PstI and BamHI sites of pCP20 (kindly provided by Dr. W.
Wackernagel, Universitat Oldenburg, Germany) (Cherepa-
nov and Wackernagel, 1995). To generate pKO5MRA,
RecA gene cassette was PCR amplified from bacterial
genome extracted from RecA-positive E. coli RR1 (ATCC
CRL31343) and cloned into SalI site of pKO5M (Tanaka et
al., 2003).
pBluescript II KS(+) (Stratagene) was digested with
HindIII, treated with T4 DNA polymerase and religated to
disrupt the HindIII site of pBluescript II KS(+). The
resultant plasmid was designated pBSDHdIII. BglIIO in
pBSDHdIII was generated by cloning 5.4 kbp BglIIO
fragment of pBC1015 (Kawaguchi et al., 1998) into the
BamHI site of pBSDHdIII. pBC1015 was kindly provided
by Dr. B. Roizman (The University of Chicago, Illinois,
USA). AflIII in pBSDV-Kp was constructed by cloning the
5.1-kbp AflIII fragment of BglIIO in pBSDHdIII (both sites
were blunt ended by treatment with T4 DNA polymerase)
into the blunt-ended EcoRV–KpnI site of pBluescript II
KS(+). To construct pCMV-UL13(F), HSV-1 UL13 ORF
without a start codon was PCR amplified and cloned into
the EcoRI–BamHI site of pFlag-CMV-2 (Sigma) in frame
with FLAG epitope. pCMV-UL13KM(F), in which lys-176of UL13 was replaced with a methionine codon, was
generated using the QuickChange Site-Directed Mutagene-
sis kit with complementary oligonucleotides containing the
specific nucleotide substitution according to the manufac-
ture’s instructions (Stratagene). EcoRV–KpnI fragment
of pCMV-UL13KM(F) containing the sequence carrying
the mutation was ligated into an EcoRV–KpnI-digested
AflIII in pBSDV-Kp to yield pUL13KM. The pKO5MRA/
UL13KM was generated by cloning the AflIII–NotI frag-
ment of pUL13KM (both sites were blunt ended by
treatment with T4 DNA polymerase) into the blunt ended
SalI site of pKO5MRA. To construct p13V-Kp, the
EcoRV–KpnI fragment of pCMV-UL13(F) was cloned into
EcoRV and KpnI sites of pBluescript II KS(+). The p13V-
Kp-Pst+, into which a silent mutation in the wobble base of
glutamine at position 219 of UL13 was introduced to create
a PstI restriction site, was generated using the QuickChange
Site-Directed Mutagenesis Kit (Stratagene) as described
above. The PstI restriction site is useful for screening of
repaired viruses and differentiation of wild type from
repaired viruses. The EcoRV–KpnI fragment of p13V-Kp-
Pst+ was ligated into EcoRV–KpnI-digested AflIII in
pBSDV-Kp to yield AflIII Pst+ in pBSDV-Kp.
Mutagenesis of viral genomes in E. coli and generation of
recombinant viruses
As a first step, we generated aUL13mutant virus (YK401)
in which a domain of UL13 encoding codons 158–418 was
substituted with the gene encoding kanamycin resistance by a
one-step mutagenesis method named ET cloning (Zhang et
al., 1998). YEbac201, E. coli DH10 strain containing HSV-
1(F)-BAC plasmid (pYEbac102) and pGETrec encoding
recombinase E and T under control of an arabinose-inducible
promoter (a generous gift from Dr. P. A. Ioannou, Murdoch
Children Research Institute, Australia) (Narayanan et al.,
1999), was grown in LB medium containing 50 Ag/ml of
ampicillin and 20 Ag/ml of chloramphenicol at 37 -C. When
the culture reached an OD600 of 0.1–0.15, 1/100 volume of
10% l-arabinose was added to induce expression of the ET
recombinase. After further incubation, the cells were har-
vested at an OD600 of 0.3–0.4 and electro-competent cells
were prepared as described elsewhere (Tanaka et al., 2003).
Linear fragments containing a gene encoding kanamycin
resistance, FRT and 50 bp of flanking UL13 sequences on
each side was generated by PCR using the primers: 5V-
agggccagggcgaagtccggcgacagctggttgttaaaatactggtaacc-
gaagttcctattctctagaaagtataggaacttcgacagcaagcgaaccggaat-3V,
and 5V-aaccccgccctacactacacgaccctcgagatccccggggccc-
gaagcttgaagttcctatactttctagagaataggaacttccggaaatgttgaatactc-
atactcttcctttttc-3Vusing pCR2.1 (Invitrogen) as template. The
primers were designed to replace codons 158–418 of UL13
with a kanamycin resistance gene. The linear PCR-
generated fragments were electroporated into the electro-
competent cells of YEbac201. The bacteria from the
electroporation were incubated at 37 -C for 4 h and plated
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ml of chloramphenicol and 20 Ag/ml of kanamycin to select
E. coli clones harboring the kanamycin resistant gene
inserted into UL13 locus. HSV-BAC DNA was isolated as
described previously (Tanaka et al., 2003) and analyzed by
PCR with appropriate primers, which led to the identifica-
tion of E. coli YEbac401 harboring the mutant HSV-BAC
plasmid pYEbac401. A UL13 deletion mutant virus YK401
(Fig. 1, line 7) was generated by transfection of pYEbac401
into rabbit skin cells as described previously (Tanaka et al.,
2003).
The next step was to remove the gene encoding
kanamycin resistance from pYEbac401. This step was
facilitated by the presence of FRT sites flanking the gene
(Cherepanov and Wackernagel, 1995). To remove the
kanamycin resistance gene from the mutant HSV-BAC,
the Flp expression plasmid pCP20Zeo was electroporated
into E. coli YEbac401. The bacteria were plated on LB agar
plates containing 20 Ag/ml of chloramphenicol and 20 Ag/
ml of zeocin and grown overnight at 28 -C. To confirm the
loss of the kanamycin resistance gene, the colonies were
restreaked in duplicate on chloramphenicol- and chlamphe-
nicol-kanamycin-containing plates and grown overnight at
37 -C. From chloramphenicol-resistant and kanamycin-
sensitive colonies, the mutated HSV-BAC DNAs were
extracted and analyzed by PCR for confirmation of loss of
the kanamycin resistance gene. One of the colonies
(YEbac402) harboring pYEbac402 was selected and used
for construction of a UL13 deletion virus YK402 (Fig. 1,
line 8). YK402 was generated by transfection of pYEbac402
into rabbit skin cells as described above (Tanaka et al.,
2003).
To construct a recombinant virus carrying a methionine
replacement of Lys-176 (K176M) in UL13, we employed a
RecA-mediated two-step homologous recombination proce-
dure (O’Connor et al., 1989; Tanaka et al., 2003; Yang et al.,
1997). In principle, this method allows introduction of any
kind of mutagenesis, including deletion, amino acid
substitution and insertion of foreign genes. Therefore, we
first attempted to introduce the K176M into the UL13 locus
of pYEbac102 in E. coli YEbac102. However, we were not
able to obtain any E. coli clones containing HSV-BAC
carrying the K176M in UL13 gene (data not shown). We
then modified the RecA-mediated recombination procedure.
Instead of E. coli YEbac102, we used E. coli YEbac401
containing the HSV-BAC (pYEbac401) in which the
kanamycin resistance gene was inserted into the UL13
locus and performed the RecA-mediated recombination
procedure to substitute the antibiotic resistance gene with
the mutant UL13 gene encoding UL13K176M. This
procedure enabled us to identify E. coli clone (YEbac403)
harboring the desired HSV-BAC (pYEbac403), based on the
sensitivity for kanamycin. Briefly, pKO5MRA/UL13KM
was electroporated into E. coli YEbac401 as described
previously (Tanaka et al., 2003). The bacteria were plated
on pre-warmed LB agar plates containing 20 Ag/ml ofchloramphenicol, 20 Ag/ml of kanamycin and 20 Ag/ml of
zeocin and incubated overnight at 43 -C. Relatively large
colonies were picked and diluted serially in LB medium,
plated on chloramphenicol–10% sucrose LB plates and
incubated overnight at 30 -C. To confirm the loss of the
replacement vector and kanamycin resistant gene, chloram-
phenicol-sucrose-resistant colonies were restreaked in dupli-
cate on chloramphenicol- and chloramphenicol-kanamycin-
containing plates and grown overnight at 30 -C. From
chloramphenicol-resistant and kanamycin-sensitive colo-
nies, the mutated HSV-BAC DNAs were extracted, ana-
lyzed by PCR and sequenced for confirmation of the desired
mutation. One of the colonies (YEbac403) harboring
pYEbac403 was selected and used for construction of a
mutant virus YK403 that carried the amino acid substitution
in lys-176 of UL13 (Fig. 1, line 9). YK403 was generated
by transfection of pYEbac403 into rabbit skin cells (Tanaka
et al., 2003). The introduction of K176M of UL13 in
YK403 was verified by sequencing.
In the recombinant virus YK404 (Fig. 1, line 10), the
original sequence in YK403 was restored by cotransfection
of YK403 DNA with AflIII Pst+ in pBSDV-Kp. Plaques
were isolated, purified and screened for the presence of PstI
site in the UL13 locus. Restoration of the original sequence
was confirmed by sequencing.
Southern blotting
Viral DNAs were digested with BglII, subjected to
electrophoresis on 0.7% agarose gels and transferred to
Hybond-N+ nylon membranes (Amersham Pharmacia).
The blots were hybridized with the appropriate DNA
probe labeled with [a-32P] dCTP by using a Rediprime II
labeling kit (Amersham Pharmacia) as instructed by the
manufacturer.
Purification of virions
Virions were purified as described previously (Kopp et
al., 2002). Briefly, nearly confluent rabbit skin cells in one
225-cm2 flask were infected with each of the viruses at an
MOI 0.01 and incubated until complete cytopathic effect
developed. The infected cell cultures were subjected to one
cycle of freezing and thawing and cellular debris was
removed by low-speed centrifugation. The virus-containing
supernatant was centrifuged for 1 h at 22,000 rpm in an
SW28 rotor (Beckman). The pellet was resuspended in
TBSal (200 mM NaCl, 2.6 mM KCl, 10 mM Tris–HCl
[pH 7.5], 20 mM MgCl2, 1.8 mM CaCl2), laid onto a
discontinuous sucrose gradient (30%, 40% and 50%
sucrose) and centrifuged for 2 h at 20,000 rpm in an
SW44Ti rotor. The virions accumulated at the boundary
between 40% and 50% sucrose and were harvested,
pelleted by centrifugation for 2 h at 20,000 rpm in an
SW41 rotor, resuspended in TBSal and subjected to
immunoblotting.
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The electrophoretically separated proteins transferred to
PVDF membranes were reacted with appropriate antibodies
as described previously (Tanaka et al., 2002). A rabbit
polyclonal antibody to UL13 was kindly provided by Dr. B.
Roizman (Ng et al., 1998). The rabbit polyclonal antibodies
to UL41, UL48 and UL34 are described elsewhere (Kato et
al., 2000; Shiba et al., 2000; Suzutani et al., 2000). A mouse
monoclonal antibody to ICP0 (H1083) was purchased from
the Goodwin Institute (Plantation, Florida, USA). A rabbit
polyclonal antibody was generated by immunization with a
synthetic peptide (Cys–Val–Lys–Ala–Arg–Arg–Pro–
Ala–Leu–Arg–Ser–Pro) that corresponds to amino acid
12 through 23 of ICP22 as described previously (Acker-
mann et al., 1985).
Determination of plaque size
Confluent monolayers of rabbit skin cells in culture
dishes were infected with each of the recombinant viruses at
an MOI of 0.0001 PFU per cell. After adsorption for 1 h, the
inoculum was removed and the cell monolayer was overlaid
with medium 199 containing 1% fetal calf serum and 160
Ag/ml of pooled human immunoglobulin (Sigma) as
described previously (Tanaka et al., 2004). Two days after
infection, 20 plaques produced by each of the recombinant
viruses were analyzed using a microscope equipped with a
DS camera control unit DS-L1 (Nikon).Acknowledgments
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